Skip to main content
Lonza to construct manufacturing site for Gamida's omidubicel
6/20/2019

Gamida and Lonza established a commercial manufacturing deal for Gamida's late-stage omidubicel for bone marrow transplant. The agreement provides for future commercial production after potential FDA approval of the drug.

Full Story: